COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.

(ERJ open research, v9.1)

Adult PAP patients experience similar #COVID19 rates to the general population, and high rates of hospitalisation and deaths, underscoring their vulnerability and the need for measures to prevent infection. The impact of iGM-CSF must be considered. https://bit.ly/3M0wKnZ.

Copyright ©The authors 2023.

Read publication

Overview publication

TitleCOVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.
Date2023-01-01
Issue nameERJ open research
Issue numberv9.1
DOI10.1183/23120541.00199-2022
PubMed36601310
AuthorsPapiris SA, Campo I, Mariani F, Kallieri M, Kolilekas L, Papaioannou AI, Gonca Chousein E, Cetinkaya E, Bonella F, Borie R, Kokosi M, Pickworth T, Molina-Molina M, Gasa M, Radzikowska E, Fijolek J, Jouneau S, Gomez E, McCarthy C, Bendstrup E, Piotrowski WJ, Pabary R, Hadchouel A, Coolen-Allou N, Alfaro T, Robalo Cordeiro C, Antonogiannaki EM, Tomos IP, Papakosta D, Kontakiotis T, Panagiotou P, Douros K, Schams A, Lettieri S, Papaevangelou V, Kanaka-Gantenbein C, Karakatsani A, Loukides S, Costabel U, Crestani B, Morgan C, Tazawa R, Bush A, Griese M & Manali ED
Read Read publication